CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
Conditions: B-Cell Non Hodgkin Lymphoma; B-Cell Acute Lymphoblastic Leukemia Intervention: Biological: anti-CD19 CAR T-cells Sponsors: Vinmec Research Institute of Stem Cell and Gene Technology; National Institute of Hematology and Blood Transfusion, Vietnam Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Blood Transusion | Genetics | Hematology | Leukemia | Lymphoma | Non-Hodgkin's Lymphoma | Research | Stem Cell Therapy | Stem Cells | Vietnam Health